The European Medicines Agency Ema has recommended the drug Daraxonrasib for adults with metastatic pancreatic cancer and hopes for progress in the fight against this deadly disease, while awaiting official market approval from the European Commission. #Bauchspeicheldrüsenkrebs #Krebsforschung #NeueMedikamente (translated)
www.spiegel.de
Bauchspeicheldrüsenkrebs: Ema empfiehlt Medikament Daraxonrasib
